Thyroid Outcome During Long-Term Gonadotropin-Releasing Hormone Agonist Treatments for Idiopathic Precocious Puberty

Journal of Adolescent Health

Volumn 40, Issue 3, 2007, Pages 252-257

  Massart, Francesco ^a   Harrell, Joshua Chuck ^b   Federico, Giovanni ^a   Saggese, Giuseppe ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Gonadotropin releasing hormone agonist; Leuprorelin acetate; Precocious puberty; Thyroid; Triptorelin

Indexed keywords

GONADORELIN AGONIST; LEUPRORELIN; THYROID ANTIBODY; THYROTROPIN; TRIPTORELIN;

ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HORMONE ACTION; HORMONE RELEASE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; THYROID DISEASE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; TREATMENT DURATION; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CHILD; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEUPROLIDE; PUBERTY, PRECOCIOUS; RETROSPECTIVE STUDIES; THYROID FUNCTION TESTS; THYROID GLAND; THYROID HORMONES; THYROTROPIN; TIME; TRIPTORELIN;

EID: 33847135182     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2006.09.024     Document Type: Article

References (27)

1. McArdle C.A., Franklin J., Green L., et al. Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors. J Endocrinol 173 (2002) 1-11
2. Kiesel L.A., Rody A., Greb R.R., et al. Clinical use of GnRH analogues. Clin Endocrinol 56 (2002) 677-687
3. Heger S., Sippell W.G., and Partsch C.J. Gonadotropin-releasing hormone analogue treatment for precocious puberty. Twenty years of experience. Endocr Dev 8 (2005) 94-125
4. Lahlou N., Carel J.C., Chaussain J.L., et al. Pharmacokinetics and pharmacodynamics of GnRH agonists: Clinical implications in pediatrics. J Pediatr Endocrinol Metab 13 (2000) 723-737
5. Bertelloni S., Baroncelli G.I., Sorrentino M.C., et al. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr 157 (1998) 363-367
6. Mul D., Bertelloni S., Carel J.C., et al. Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: Final height results. Horm Res 58 (2002) 1-7
7. Carel J.C., Lahlou N., Guazzarotti L., et al. Treatment of central precocious puberty with depot leuprorelin. Eur J Endocrinol 132 (1995) 699-704
8. Tanaka T., Niimi H., Matsuo N., et al. Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: Evaluation of effectiveness of treatment and recovery of gonadal function. J Clin Endocrinol Metab 90 (2005) 1371-1376
9. Klein K.O., Barnes K.M., Jones J.V., et al. Increased final height in precocious puberty after long-term treatment with LHRH agonists: The NIH experience. J Clin Endocrinol Metab 86 (2001) 4711-4716
10. Jay N., Mansfield M.J., Blizzard R.M., et al. Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 75 (1992) 890-894
11. Tonini G., and Lazzerini M. Side effects of GnRH analogue treatment in childhood. J Pediatr Endocrinol Metab 13 (2000) 795-803
12. Massart F., Parrino R., Placidi G., et al. Prolactin secretion before, during, and after chronic gonadotropin-releasing hormone agonist treatments in children. Fertil Steril 83 (2005) 719-723
13. Chantilis S.J., Barnett-Hamm C., Byrd W.E., et al. The effect of gonadotropin-releasing hormone agonist on thyroid-stimulating hormone and prolactin secretion in adult premenopausal women. Fertil Steril 64 (1995) 698-702
14. Cedars M.I., Steingold K.A., Lu J.H., et al. Pituitary function before, during, and after chronic gonadotropin-releasing hormone agonist therapy. Fertil Steril 58 (1992) 1104-1107
15. Amino N., Hidaka Y., Takano T., et al. Possible induction of Graves' disease and painless thyroiditis by gonadotropin-releasing hormone analogues. Thyroid 13 (2003) 815-818
16. Sonoda M., Nagata Y., Inoue Y., et al. A case of transient hyperthyroidism during pseudomenopausal therapy. Acta Obstet Gynaecol Jpn 51 (1999) 857-960
17. Fukata S., Kubota S., Ito M., et al. A case of painless thyroiditis occurred after administration of nafarelin. Hormone Rinsho 47 (1999) 90-92
18. Kasayama S., Miyake S., and Samejima Y. Transient thyrotoxicosis and hypothyroidism following administration of the GnRH agonist leuprolide acetate. Endocr J 47 (2000) 783-785
19. Eyal O., and Rose S.R. Autoimmune thyroiditis during leuprolide acetate treatment. J Pediatr 144 (2004) 394-396
20. Tanaka T., Umesaki N., and Ogita S. Altered sensitivity to anti-endometriosis medicines in an adenomyosis patient with thyroid dysfunction. Gynecol Endocrinol 14 (2000) 388-391
21. Redmond G.P. Thyroid dysfunction and women's reproductive health. Thyroid 14 (2004) S5-S15
22. Mazer N.A. Interaction of estrogen therapy and thyroid hormone replacement in postmenopausal women. Thyroid 14 (2004) S27-S34
23. Iughetti L., Predieri B., Ferrari M., et al. Diagnosis of central precocius puberty: Endocrine assessment. J Pediatr Endocrinol Metab 13 (2000) 709-715
24. Aghini-Lombardi F., Antonangeli L., Pinchera A., et al. Effect of iodized salt on thyroid volume of children living in an area previously characterized by moderate iodine deficiency. J Clin Endocrinol Metab 82 (1997) 1136-1139
25. Anasti J.N., Flack M.R., Froehlich J., et al. A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab 80 (1995) 276-279
26. Cheung T., Lo K.W., Lam C.W., et al. A crossover study of triptorelin and leuprorelin acetate. Fertil Steril 74 (2000) 299-305
27. Martino E., Bartalena L., Bogazzi F., et al. The effects of amiodarone on the thyroid. Endocr Rev 22 (2001) 240-254